Nucleic acid sequence comprising the RNA packaging signal of a group 1 coronavirus and the applications thereof

Details for Australian Patent Application No. 2003209766 (hide)

Owner Consejo Superior de Investigaciones Cientificas

Inventors Ortego Alonso, Javier; Enjuanes Sanchez, Luis; Escors Murugarren, David

Agent Shelston IP

Pub. Number AU-B-2003209766

PCT Number PCT/ES03/00038

PCT Pub. Number WO2003/062424

Priority P200200158 24.01.02 ES

Filing date 24 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 6 December 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/17 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): P200200158 24.01.02 ES

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003209766

6 December 2007 Application Accepted

  Published as AU-B-2003209766

17 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003209767-NOVEL STRATEGY FOR MODULATING T CELL ACTIVATION WHICH IS BASED ON REGULATING THE CD3 - NCK INTERACTION

2003209765-IMPROVED BUSINESS CARD FILE